heartburn

November 27, 2019

Zantac recalled for carcinogen levels above FDA standards

The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer. The recall includes oral tablets, capsules, and syrup.

By VUMC News and Communications
December 19, 2017

Surgical group works to expand heartburn treatment options

For three years, 79-year-old Jerry Mock didn’t fully enjoy family vacations or gatherings with friends because his gastro-esophageal reflux disease (GERD) was so debilitating that eating even a bite of food after 1 p.m. guaranteed he’d have intense burning pain in his throat and chest that night.

By Jill Clendening